ESR1 and neoplasm: Appropriate treatment regimens need to be selected based on clinical and pathological characteristics such as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER-2), TNM stage, tumor grade, etc. (12).